Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 20/20 | 0.82 |
| ▸ | GIPR | P48546 | 20/20 | 0.82 |
| ▸ | GLP1R | P43220 | 4/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2652343 | 1.00 | GCGR (0.82) | GCGRGIPRGLP1R | |
| SCHEMBL9071705 | 0.93 | GCGR (0.79) | GCGRGIPRGLP1R | |
| SCHEMBL2665526 | 0.93 | GCGR (0.79) | GCGRGIPRGLP1R | |
| SCHEMBL2665668 | 0.91 | GCGR (0.69) | GCGRGIPRGLP1R | |
| SCHEMBL2652720 | 0.90 | GCGR (1.00) | GCGRGIPRGLP1R | |
| SCHEMBL2652716 | 0.90 | GCGR (1.00) | GCGRGIPRGLP1R | |
| SCHEMBL2651188 | 0.90 | GCGR (1.00) | GCGRGIPRGLP1R | |
| SCHEMBL2651186 | 0.90 | GCGR (1.00) | GCGRGIPRGLP1R | |
| SCHEMBL2651575 | 0.90 | GCGR (1.00) | GCGRGIPRGLP1R | |
| SCHEMBL6366266 | 0.89 | GCGR (0.80) | GCGRGIPRGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040024045-A1 | Glucagon antagonists/inverse agonists | PFIZER INC | 2004-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024045-A1 | Glucagon antagonists/inverse agonists | GLP1R, GPR119, GCGR | GCGR 3/4885GIPR 4/4885GLP1R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.